img

Global Huntington's Disease Treatment Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Huntington's Disease Treatment Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Huntington's disease is an infrequent inherited neurodegenerative disease that affects various generations. The impact of this disease is high when the age is between 30 and 50, hampering their ability to work, care for families, and eventually complete daily tasks. The generality difers by more than ten-fold between geographical areas, which can be associated with differences in case ascertainments and diagnostic criteria. As a result, the generality of enlarged replications in the general population may be larger than expected. The Asian population has continuously had a lower generality, while Europe, North America, and Australia have a higher generality.
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Huntington's Disease Treatment was estimated at US$ million in the year 2024, is projected to reach a revised size of US$ million by 2034, growing at a CAGR of % during the forecast period 2024-2034.
North American market for Huntington's Disease Treatment was valued at $ million in 2024 and will reach $ million by 2034, at a CAGR of % during the forecast period of 2023 through 2034.
Asia-Pacific market for Huntington's Disease Treatment was valued at $ million in 2024 and will reach $ million by 2034, at a CAGR of % during the forecast period of 2023 through 2034.
Europe market for Huntington's Disease Treatment was valued at $ million in 2024 and will reach $ million by 2034, at a CAGR of % during the forecast period of 2023 through 2034..
Report Scope
This report aims to provide a comprehensive presentation of the global market for Huntington's Disease Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Huntington's Disease Treatment.
The Huntington's Disease Treatment market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2018 to 2034. This report segments the global Huntington's Disease Treatment market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Huntington's Disease Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
Market Segmentation
This report covers the Huntington's Disease Treatment segments by manufacturers, by type, by application, by region and country, and provides market size (value, volume and average price) and CAGR for the history and forecast period (2018-2023, 2024-2034), considering 2024 as the base year. It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.



By Company


AInylam Pharmaceuticals Inc
AmpliPhi Biosciences Corp
Ceregene Inc
Lundbeck
Prana Biotechnology Limited
Teva Pharmaceutical Industries Ltd
Cortex Pharmaceuticals Inc
Vertex Pharmaceuticals Incorporated
Auspex Pharmaceuticals
SOM Biotech
GlaxoSmithKline
Siena Biotech
Raptor Pharmaceutical
Pfizer
Palobiofarma
Omeros
Ipsen
Valeant Pharmaceuticals International Inc
Segment by Type
Tetrabenazine
Selective Serotonin Reuptake Inhibitor
Chlorpromazine
Haloperidol
Risperidone
Olanzapine
Clozapine
Other

Segment by Application


Hospital
Specialty Clinic
other

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter OneIntroduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter TwoDetailed analysis of Huntington's Disease Treatment manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger and acquisition information, etc.
Chapter ThreeSales, revenue of Huntington's Disease Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter FourIntroduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and NineNorth America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter TenProvides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven Analysis of industrial chain, key raw materials, manufacturing cost and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter TwelveResearch Findings and Conclusion

Table of Content

1 Huntington's Disease Treatment Market Overview
1.1 Huntington's Disease Treatment Product Overview
1.2 Huntington's Disease Treatment Market Segment by Type
1.2.1 Tetrabenazine
1.2.2 Selective Serotonin Reuptake Inhibitor
1.2.3 Chlorpromazine
1.2.4 Haloperidol
1.2.5 Risperidone
1.2.6 Olanzapine
1.2.7 Clozapine
1.2.8 Other
1.3 Global Huntington's Disease Treatment Market Size by Type
1.3.1 Global Huntington's Disease Treatment Market Size Overview by Type (2018-2034)
1.3.2 Global Huntington's Disease Treatment Historic Market Size Review by Type (2018-2023)
1.3.3 Global Huntington's Disease Treatment Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Huntington's Disease Treatment Sales Breakdown by Type (2018-2023)
1.4.2 Europe Huntington's Disease Treatment Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Huntington's Disease Treatment Sales Breakdown by Type (2018-2023)
1.4.4 I194 Huntington's Disease Treatment Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Huntington's Disease Treatment Sales Breakdown by Type (2018-2023)
2 Global Huntington's Disease Treatment Market Competition by Company
2.1 Global Top Players by Huntington's Disease Treatment Sales (2018-2023)
2.2 Global Top Players by Huntington's Disease Treatment Revenue (2018-2023)
2.3 Global Top Players by Huntington's Disease Treatment Price (2018-2023)
2.4 Global Top Manufacturers Huntington's Disease Treatment Manufacturing Base Distribution, Sales Area, Product Type
2.5 Huntington's Disease Treatment Market Competitive Situation and Trends
2.5.1 Huntington's Disease Treatment Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Huntington's Disease Treatment Sales and Revenue in 2024
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Huntington's Disease Treatment as of 2024)
2.7 Date of Key Manufacturers Enter into Huntington's Disease Treatment Market
2.8 Key Manufacturers Huntington's Disease Treatment Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Huntington's Disease Treatment Status and Outlook by Region
3.1 Global Huntington's Disease Treatment Market Size and CAGR by Region: 2018 VS 2024 VS 2034
3.2 Global Huntington's Disease Treatment Historic Market Size by Region
3.2.1 Global Huntington's Disease Treatment Sales in Volume by Region (2018-2023)
3.2.2 Global Huntington's Disease Treatment Sales in Value by Region (2018-2023)
3.2.3 Global Huntington's Disease Treatment Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Huntington's Disease Treatment Forecasted Market Size by Region
3.3.1 Global Huntington's Disease Treatment Sales in Volume by Region (2024-2034)
3.3.2 Global Huntington's Disease Treatment Sales in Value by Region (2024-2034)
3.3.3 Global Huntington's Disease Treatment Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Huntington's Disease Treatment by Application
4.1 Huntington's Disease Treatment Market Segment by Application
4.1.1 Hospital
4.1.2 Specialty Clinic
4.1.3 other
4.2 Global Huntington's Disease Treatment Market Size by Application
4.2.1 Global Huntington's Disease Treatment Market Size Overview by Application (2018-2034)
4.2.2 Global Huntington's Disease Treatment Historic Market Size Review by Application (2018-2023)
4.2.3 Global Huntington's Disease Treatment Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Huntington's Disease Treatment Sales Breakdown by Application (2018-2023)
4.3.2 Europe Huntington's Disease Treatment Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Huntington's Disease Treatment Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Huntington's Disease Treatment Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Huntington's Disease Treatment Sales Breakdown by Application (2018-2023)
5 North America Huntington's Disease Treatment by Country
5.1 North America Huntington's Disease Treatment Historic Market Size by Country
5.1.1 North America Huntington's Disease Treatment Market Size Growth Rate (CAGR) by Country: 2018 VS 2024 VS 2034
5.1.2 North America Huntington's Disease Treatment Sales in Volume by Country (2018-2023)
5.1.3 North America Huntington's Disease Treatment Sales in Value by Country (2018-2023)
5.2 North America Huntington's Disease Treatment Forecasted Market Size by Country
5.2.1 North America Huntington's Disease Treatment Sales in Volume by Country (2024-2034)
5.2.2 North America Huntington's Disease Treatment Sales in Value by Country (2024-2034)
6 Europe Huntington's Disease Treatment by Country
6.1 Europe Huntington's Disease Treatment Historic Market Size by Country
6.1.1 Europe Huntington's Disease Treatment Market Size Growth Rate (CAGR) by Country: 2018 VS 2024 VS 2034
6.1.2 Europe Huntington's Disease Treatment Sales in Volume by Country (2018-2023)
6.1.3 Europe Huntington's Disease Treatment Sales in Value by Country (2018-2023)
6.2 Europe Huntington's Disease Treatment Forecasted Market Size by Country
6.2.1 Europe Huntington's Disease Treatment Sales in Volume by Country (2024-2034)
6.2.2 Europe Huntington's Disease Treatment Sales in Value by Country (2024-2034)
7 Asia-Pacific Huntington's Disease Treatment by Region
7.1 Asia-Pacific Huntington's Disease Treatment Historic Market Size by Region
7.1.1 Asia-Pacific Huntington's Disease Treatment Market Size Growth Rate (CAGR) by Region: 2018 VS 2024 VS 2034
7.1.2 Asia-Pacific Huntington's Disease Treatment Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Huntington's Disease Treatment Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Huntington's Disease Treatment Forecasted Market Size by Region
7.2.1 Asia-Pacific Huntington's Disease Treatment Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Huntington's Disease Treatment Sales in Value by Region (2024-2034)
8 Latin America Huntington's Disease Treatment by Country
8.1 Latin America Huntington's Disease Treatment Historic Market Size by Country
8.1.1 Latin America Huntington's Disease Treatment Market Size Growth Rate (CAGR) by Country: 2018 VS 2024 VS 2034
8.1.2 Latin America Huntington's Disease Treatment Sales in Volume by Country (2018-2023)
8.1.3 Latin America Huntington's Disease Treatment Sales in Value by Country (2018-2023)
8.2 Latin America Huntington's Disease Treatment Forecasted Market Size by Country
8.2.1 Latin America Huntington's Disease Treatment Sales in Volume by Country (2024-2034)
8.2.2 Latin America Huntington's Disease Treatment Sales in Value by Country (2024-2034)
9 Middle East and Africa Huntington's Disease Treatment by Country
9.1 Middle East and Africa Huntington's Disease Treatment Historic Market Size by Country
9.1.1 Middle East and Africa Huntington's Disease Treatment Market Size Growth Rate (CAGR) by Country: 2018 VS 2024 VS 2034
9.1.2 Middle East and Africa Huntington's Disease Treatment Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Huntington's Disease Treatment Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Huntington's Disease Treatment Forecasted Market Size by Country
9.2.1 Middle East and Africa Huntington's Disease Treatment Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Huntington's Disease Treatment Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 AInylam Pharmaceuticals Inc
10.1.1 AInylam Pharmaceuticals Inc Company Information
10.1.2 AInylam Pharmaceuticals Inc Introduction and Business Overview
10.1.3 AInylam Pharmaceuticals Inc Huntington's Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
10.1.4 AInylam Pharmaceuticals Inc Huntington's Disease Treatment Products Offered
10.1.5 AInylam Pharmaceuticals Inc Recent Development
10.2 AmpliPhi Biosciences Corp
10.2.1 AmpliPhi Biosciences Corp Company Information
10.2.2 AmpliPhi Biosciences Corp Introduction and Business Overview
10.2.3 AmpliPhi Biosciences Corp Huntington's Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
10.2.4 AmpliPhi Biosciences Corp Huntington's Disease Treatment Products Offered
10.2.5 AmpliPhi Biosciences Corp Recent Development
10.3 Ceregene Inc
10.3.1 Ceregene Inc Company Information
10.3.2 Ceregene Inc Introduction and Business Overview
10.3.3 Ceregene Inc Huntington's Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Ceregene Inc Huntington's Disease Treatment Products Offered
10.3.5 Ceregene Inc Recent Development
10.4 Lundbeck
10.4.1 Lundbeck Company Information
10.4.2 Lundbeck Introduction and Business Overview
10.4.3 Lundbeck Huntington's Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Lundbeck Huntington's Disease Treatment Products Offered
10.4.5 Lundbeck Recent Development
10.5 Prana Biotechnology Limited
10.5.1 Prana Biotechnology Limited Company Information
10.5.2 Prana Biotechnology Limited Introduction and Business Overview
10.5.3 Prana Biotechnology Limited Huntington's Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Prana Biotechnology Limited Huntington's Disease Treatment Products Offered
10.5.5 Prana Biotechnology Limited Recent Development
10.6 Teva Pharmaceutical Industries Ltd
10.6.1 Teva Pharmaceutical Industries Ltd Company Information
10.6.2 Teva Pharmaceutical Industries Ltd Introduction and Business Overview
10.6.3 Teva Pharmaceutical Industries Ltd Huntington's Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Teva Pharmaceutical Industries Ltd Huntington's Disease Treatment Products Offered
10.6.5 Teva Pharmaceutical Industries Ltd Recent Development
10.7 Cortex Pharmaceuticals Inc
10.7.1 Cortex Pharmaceuticals Inc Company Information
10.7.2 Cortex Pharmaceuticals Inc Introduction and Business Overview
10.7.3 Cortex Pharmaceuticals Inc Huntington's Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Cortex Pharmaceuticals Inc Huntington's Disease Treatment Products Offered
10.7.5 Cortex Pharmaceuticals Inc Recent Development
10.8 Vertex Pharmaceuticals Incorporated
10.8.1 Vertex Pharmaceuticals Incorporated Company Information
10.8.2 Vertex Pharmaceuticals Incorporated Introduction and Business Overview
10.8.3 Vertex Pharmaceuticals Incorporated Huntington's Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Vertex Pharmaceuticals Incorporated Huntington's Disease Treatment Products Offered
10.8.5 Vertex Pharmaceuticals Incorporated Recent Development
10.9 Auspex Pharmaceuticals
10.9.1 Auspex Pharmaceuticals Company Information
10.9.2 Auspex Pharmaceuticals Introduction and Business Overview
10.9.3 Auspex Pharmaceuticals Huntington's Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Auspex Pharmaceuticals Huntington's Disease Treatment Products Offered
10.9.5 Auspex Pharmaceuticals Recent Development
10.10 SOM Biotech
10.10.1 SOM Biotech Company Information
10.10.2 SOM Biotech Introduction and Business Overview
10.10.3 SOM Biotech Huntington's Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
10.10.4 SOM Biotech Huntington's Disease Treatment Products Offered
10.10.5 SOM Biotech Recent Development
10.11 GlaxoSmithKline
10.11.1 GlaxoSmithKline Company Information
10.11.2 GlaxoSmithKline Introduction and Business Overview
10.11.3 GlaxoSmithKline Huntington's Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
10.11.4 GlaxoSmithKline Huntington's Disease Treatment Products Offered
10.11.5 GlaxoSmithKline Recent Development
10.12 Siena Biotech
10.12.1 Siena Biotech Company Information
10.12.2 Siena Biotech Introduction and Business Overview
10.12.3 Siena Biotech Huntington's Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Siena Biotech Huntington's Disease Treatment Products Offered
10.12.5 Siena Biotech Recent Development
10.13 Raptor Pharmaceutical
10.13.1 Raptor Pharmaceutical Company Information
10.13.2 Raptor Pharmaceutical Introduction and Business Overview
10.13.3 Raptor Pharmaceutical Huntington's Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Raptor Pharmaceutical Huntington's Disease Treatment Products Offered
10.13.5 Raptor Pharmaceutical Recent Development
10.14 Pfizer
10.14.1 Pfizer Company Information
10.14.2 Pfizer Introduction and Business Overview
10.14.3 Pfizer Huntington's Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Pfizer Huntington's Disease Treatment Products Offered
10.14.5 Pfizer Recent Development
10.15 Palobiofarma
10.15.1 Palobiofarma Company Information
10.15.2 Palobiofarma Introduction and Business Overview
10.15.3 Palobiofarma Huntington's Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Palobiofarma Huntington's Disease Treatment Products Offered
10.15.5 Palobiofarma Recent Development
10.16 Omeros
10.16.1 Omeros Company Information
10.16.2 Omeros Introduction and Business Overview
10.16.3 Omeros Huntington's Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Omeros Huntington's Disease Treatment Products Offered
10.16.5 Omeros Recent Development
10.17 Ipsen
10.17.1 Ipsen Company Information
10.17.2 Ipsen Introduction and Business Overview
10.17.3 Ipsen Huntington's Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
10.17.4 Ipsen Huntington's Disease Treatment Products Offered
10.17.5 Ipsen Recent Development
10.18 Valeant Pharmaceuticals International Inc
10.18.1 Valeant Pharmaceuticals International Inc Company Information
10.18.2 Valeant Pharmaceuticals International Inc Introduction and Business Overview
10.18.3 Valeant Pharmaceuticals International Inc Huntington's Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
10.18.4 Valeant Pharmaceuticals International Inc Huntington's Disease Treatment Products Offered
10.18.5 Valeant Pharmaceuticals International Inc Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Huntington's Disease Treatment Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Huntington's Disease Treatment Industrial Chain Analysis
11.4 Huntington's Disease Treatment Market Dynamics
11.4.1 Huntington's Disease Treatment Industry Trends
11.4.2 Huntington's Disease Treatment Market Drivers
11.4.3 Huntington's Disease Treatment Market Challenges
11.4.4 Huntington's Disease Treatment Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Huntington's Disease Treatment Distributors
12.3 Huntington's Disease Treatment Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Tetrabenazine
Table 2. Major Company of Selective Serotonin Reuptake Inhibitor
Table 3. Major Company of Chlorpromazine
Table 4. Major Company of Haloperidol
Table 5. Major Company of Risperidone
Table 6. Major Company of Olanzapine
Table 7. Major Company of Clozapine
Table 8. Major Company of Other
Table 9. Global Huntington's Disease Treatment Sales by Type 2018 VS 2024 VS 2034 (US$ Million)
Table 10. Global Huntington's Disease Treatment Sales by Type (2018-2023) & (K Units)
Table 11. Global Huntington's Disease Treatment Sales Market Share in Volume by Type (2018-2023)
Table 12. Global Huntington's Disease Treatment Sales by Type (2018-2023) & (US& Million)
Table 13. Global Huntington's Disease Treatment Market Share in Value by Type (2018-2023)
Table 14. Global Huntington's Disease Treatment Price by Type (2018-2023) & (US$/Unit)
Table 15. Global Huntington's Disease Treatment Sales by Type (2024-2034) & (K Units)
Table 16. Global Huntington's Disease Treatment Sales Market Share in Volume by Type (2024-2034)
Table 17. Global Huntington's Disease Treatment Sales by Type (2024-2034) & (US$ Million)
Table 18. Global Huntington's Disease Treatment Sales Market Share in Value by Type (2024-2034)
Table 19. Global Huntington's Disease Treatment Price by Type (2024-2034) & (US$/Unit)
Table 20. North America Huntington's Disease Treatment Sales by Type (2018-2023) & (K Units)
Table 21. North America Huntington's Disease Treatment Sales by Type (2018-2023) & (US$ Million)
Table 22. Europe Huntington's Disease Treatment Sales (K Units) by Type (2018-2023)
Table 23. Europe Huntington's Disease Treatment Sales by Type (2018-2023) & (US$ Million)
Table 24. Asia-Pacific Huntington's Disease Treatment Sales (K Units) by Type (2018-2023)
Table 25. Asia-Pacific Huntington's Disease Treatment Sales by Type (2018-2023) & (US$ Million)
Table 26. Latin America Huntington's Disease Treatment Sales (K Units) by Type (2018-2023)
Table 27. Latin America Huntington's Disease Treatment Sales by Type (2018-2023) & (US$ Million)
Table 28. Middle East and Africa Huntington's Disease Treatment Sales (K Units) by Type (2018-2023)
Table 29. Middle East and Africa Huntington's Disease Treatment Sales by Type (2018-2023) & (US$ Million)
Table 30. Global Huntington's Disease Treatment Sales by Company (2018-2023) & (K Units)
Table 31. Global Huntington's Disease Treatment Sales Share by Company (2018-2023)
Table 32. Global Huntington's Disease Treatment Revenue by Company (2018-2023) & (US$ Million)
Table 33. Global Huntington's Disease Treatment Revenue Share by Company (2018-2023)
Table 34. Global Market Huntington's Disease Treatment Price by Company (2018-2023) & (US$/Unit)
Table 35. Global Huntington's Disease Treatment Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 36. Global Huntington's Disease Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 37. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Huntington's Disease Treatment as of 2024)
Table 38. Date of Key Manufacturers Enter into Huntington's Disease Treatment Market
Table 39. Key Manufacturers Huntington's Disease Treatment Product Type
Table 40. Mergers & Acquisitions, Expansion Plans
Table 41. Global Huntington's Disease Treatment Market Size Comparison by Region (US$ Million): 2018 VS 2024 VS 2034
Table 42. Global Huntington's Disease Treatment Sales by Region (2018-2023) & (K Units)
Table 43. Global Huntington's Disease Treatment Sales Market Share in Volume by Region (2018-2023)
Table 44. Global Huntington's Disease Treatment Sales by Region (2018-2023) & (US$ Million)
Table 45. Global Huntington's Disease Treatment Sales Market Share in Value by Region (2018-2023)
Table 46. Global Huntington's Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 47. Global Huntington's Disease Treatment Sales by Region (2024-2034) & (K Units)
Table 48. Global Huntington's Disease Treatment Sales Market Share in Volume by Region (2024-2034)
Table 49. Global Huntington's Disease Treatment Sales by Region (2024-2034) & (US$ Million)
Table 50. Global Huntington's Disease Treatment Sales Market Share in Value by Region (2024-2034)
Table 51. Global Huntington's Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 52. Global Huntington's Disease Treatment Sales by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 53. Global Huntington's Disease Treatment Sales by Application (2018-2023) & (K Units)
Table 54. Global Huntington's Disease Treatment Sales Market Share in Volume by Application (2018-2023)
Table 55. Global Huntington's Disease Treatment Sales by Application (2018-2023) & (US$ Million)
Table 56. Global Huntington's Disease Treatment Sales Market Share in Value by Application (2018-2023)
Table 57. Global Huntington's Disease Treatment Price by Application (2018-2023) & (US$/Unit)
Table 58. Global Huntington's Disease Treatment Sales by Application (2024-2034) & (K Units)
Table 59. Global Huntington's Disease Treatment Sales Market Share in Volume by Application (2024-2034)
Table 60. Global Huntington's Disease Treatment Sales by Application (2024-2034) & (US$ Million)
Table 61. Global Huntington's Disease Treatment Sales Market Share in Value by Application (2024-2034)
Table 62. Global Huntington's Disease Treatment Price by Application (2024-2034) & (US$/Unit)
Table 63. North America Huntington's Disease Treatment Sales by Application (2018-2023) (K Units)
Table 64. North America Huntington's Disease Treatment Sales by Application (2018-2023) & (US$ Million)
Table 65. Europe Huntington's Disease Treatment Sales by Application (2018-2023) (K Units)
Table 66. Europe Huntington's Disease Treatment Sales by Application (2018-2023) & (US$ Million)
Table 67. Asia-Pacific Huntington's Disease Treatment Sales by Application (2018-2023) (K Units)
Table 68. Asia-Pacific Huntington's Disease Treatment Sales by Application (2018-2023) & (US$ Million)
Table 69. Latin America Huntington's Disease Treatment Sales by Application (2018-2023) (K Units)
Table 70. Latin America Huntington's Disease Treatment Sales by Application (2018-2023) & (US$ Million)
Table 71. Middle East and Africa Huntington's Disease Treatment Sales by Application (2018-2023) (K Units)
Table 72. Middle East and Africa Huntington's Disease Treatment Sales by Application (2018-2023) & (US$ Million)
Table 73. North America Huntington's Disease Treatment Sales by Country (2018-2023) & (K Units)
Table 74. North America Huntington's Disease Treatment Sales Market Share in Volume by Country (2018-2023)
Table 75. North America Huntington's Disease Treatment Sales by Country (2018-2023) & (US$ Million)
Table 76. North America Huntington's Disease Treatment Sales Market Share in Value by Country (2018-2023)
Table 77. North America Huntington's Disease Treatment Sales by Country (2024-2034) & (K Units)
Table 78. North America Huntington's Disease Treatment Sales Market Share in Volume by Country (2024-2034)
Table 79. North America Huntington's Disease Treatment Sales by Country (2024-2034) & (US$ Million)
Table 80. North America Huntington's Disease Treatment Sales Market Share in Value by Country (2024-2034)
Table 81. Europe Huntington's Disease Treatment Sales by Country (2018-2023) & (K Units)
Table 82. Europe Huntington's Disease Treatment Sales Market Share in Volume by Country (2018-2023)
Table 83. Europe Huntington's Disease Treatment Sales by Country (2018-2023) & (US$ Million)
Table 84. Europe Huntington's Disease Treatment Sales Market Share in Value by Country (2018-2023)
Table 85. Europe Huntington's Disease Treatment Sales by Country (2024-2034) & (K Units)
Table 86. Europe Huntington's Disease Treatment Sales Market Share in Volume by Country (2024-2034)
Table 87. Europe Huntington's Disease Treatment Sales by Country (2024-2034) & (US$ Million)
Table 88. Europe Huntington's Disease Treatment Sales Market Share in Value by Country (2024-2034)
Table 89. Asia-Pacific Huntington's Disease Treatment Sales by Region (2018-2023) & (K Units)
Table 90. Asia-Pacific Huntington's Disease Treatment Sales Market Share in Volume by Region (2018-2023)
Table 91. Asia-Pacific Huntington's Disease Treatment Sales by Region (2018-2023) & (US$ Million)
Table 92. Asia-Pacific Huntington's Disease Treatment Sales Market Share in Value by Region (2018-2023)
Table 93. Asia-Pacific Huntington's Disease Treatment Sales by Region (2024-2034) & (K Units)
Table 94. Asia-Pacific Huntington's Disease Treatment Sales Market Share in Volume by Region (2024-2034)
Table 95. Asia-Pacific Huntington's Disease Treatment Sales by Region (2024-2034) & (US$ Million)
Table 96. Asia-Pacific Huntington's Disease Treatment Sales Market Share in Value by Region (2024-2034)
Table 97. Latin America Huntington's Disease Treatment Sales by Country (2018-2023) & (K Units)
Table 98. Latin America Huntington's Disease Treatment Sales Market Share in Volume by Country (2018-2023)
Table 99. Latin America Huntington's Disease Treatment Sales by Country (2018-2023) & (US$ Million)
Table 100. Latin America Huntington's Disease Treatment Sales Market Share in Value by Country (2018-2023)
Table 101. Latin America Huntington's Disease Treatment Sales by Country (2024-2034) & (K Units)
Table 102. Latin America Huntington's Disease Treatment Sales Market Share in Volume by Country (2024-2034)
Table 103. Latin America Huntington's Disease Treatment Sales by Country (2024-2034) & (US$ Million)
Table 104. Latin America Huntington's Disease Treatment Sales Market Share in Value by Country (2024-2034)
Table 105. Middle East and Africa Huntington's Disease Treatment Sales by Country (2018-2023) & (K Units)
Table 106. Middle East and Africa Huntington's Disease Treatment Sales Market Share in Volume by Country (2018-2023)
Table 107. Middle East and Africa Huntington's Disease Treatment Sales by Country (2018-2023) & (US$ Million)
Table 108. Middle East and Africa Huntington's Disease Treatment Sales Market Share in Value by Country (2018-2023)
Table 109. Middle East and Africa Huntington's Disease Treatment Sales by Country (2024-2034) & (K Units)
Table 110. Middle East and Africa Huntington's Disease Treatment Sales Market Share in Volume by Country (2024-2034)
Table 111. Middle East and Africa Huntington's Disease Treatment Sales by Country (2024-2034) & (US$ Million)
Table 112. Middle East and Africa Huntington's Disease Treatment Sales Market Share in Value by Country (2024-2034)
Table 113. AInylam Pharmaceuticals Inc Company Information
Table 114. AInylam Pharmaceuticals Inc Introduction and Business Overview
Table 115. AInylam Pharmaceuticals Inc Huntington's Disease Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. AInylam Pharmaceuticals Inc Huntington's Disease Treatment Product
Table 117. AInylam Pharmaceuticals Inc Recent Development
Table 118. AmpliPhi Biosciences Corp Company Information
Table 119. AmpliPhi Biosciences Corp Introduction and Business Overview
Table 120. AmpliPhi Biosciences Corp Huntington's Disease Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. AmpliPhi Biosciences Corp Huntington's Disease Treatment Product
Table 122. AmpliPhi Biosciences Corp Recent Development
Table 123. Ceregene Inc Company Information
Table 124. Ceregene Inc Introduction and Business Overview
Table 125. Ceregene Inc Huntington's Disease Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Ceregene Inc Huntington's Disease Treatment Product
Table 127. Ceregene Inc Recent Development
Table 128. Lundbeck Company Information
Table 129. Lundbeck Introduction and Business Overview
Table 130. Lundbeck Huntington's Disease Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Lundbeck Huntington's Disease Treatment Product
Table 132. Lundbeck Recent Development
Table 133. Prana Biotechnology Limited Company Information
Table 134. Prana Biotechnology Limited Introduction and Business Overview
Table 135. Prana Biotechnology Limited Huntington's Disease Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Prana Biotechnology Limited Huntington's Disease Treatment Product
Table 137. Prana Biotechnology Limited Recent Development
Table 138. Teva Pharmaceutical Industries Ltd Company Information
Table 139. Teva Pharmaceutical Industries Ltd Introduction and Business Overview
Table 140. Teva Pharmaceutical Industries Ltd Huntington's Disease Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. Teva Pharmaceutical Industries Ltd Huntington's Disease Treatment Product
Table 142. Teva Pharmaceutical Industries Ltd Recent Development
Table 143. Cortex Pharmaceuticals Inc Company Information
Table 144. Cortex Pharmaceuticals Inc Introduction and Business Overview
Table 145. Cortex Pharmaceuticals Inc Huntington's Disease Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 146. Cortex Pharmaceuticals Inc Huntington's Disease Treatment Product
Table 147. Cortex Pharmaceuticals Inc Recent Development
Table 148. Vertex Pharmaceuticals Incorporated Company Information
Table 149. Vertex Pharmaceuticals Incorporated Introduction and Business Overview
Table 150. Vertex Pharmaceuticals Incorporated Huntington's Disease Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 151. Vertex Pharmaceuticals Incorporated Huntington's Disease Treatment Product
Table 152. Vertex Pharmaceuticals Incorporated Recent Development
Table 153. Auspex Pharmaceuticals Company Information
Table 154. Auspex Pharmaceuticals Introduction and Business Overview
Table 155. Auspex Pharmaceuticals Huntington's Disease Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 156. Auspex Pharmaceuticals Huntington's Disease Treatment Product
Table 157. Auspex Pharmaceuticals Recent Development
Table 158. SOM Biotech Company Information
Table 159. SOM Biotech Introduction and Business Overview
Table 160. SOM Biotech Huntington's Disease Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 161. SOM Biotech Huntington's Disease Treatment Product
Table 162. SOM Biotech Recent Development
Table 163. GlaxoSmithKline Company Information
Table 164. GlaxoSmithKline Introduction and Business Overview
Table 165. GlaxoSmithKline Huntington's Disease Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 166. GlaxoSmithKline Huntington's Disease Treatment Product
Table 167. GlaxoSmithKline Recent Development
Table 168. Siena Biotech Company Information
Table 169. Siena Biotech Introduction and Business Overview
Table 170. Siena Biotech Huntington's Disease Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 171. Siena Biotech Huntington's Disease Treatment Product
Table 172. Siena Biotech Recent Development
Table 173. Raptor Pharmaceutical Company Information
Table 174. Raptor Pharmaceutical Introduction and Business Overview
Table 175. Raptor Pharmaceutical Huntington's Disease Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 176. Raptor Pharmaceutical Huntington's Disease Treatment Product
Table 177. Raptor Pharmaceutical Recent Development
Table 178. Pfizer Company Information
Table 179. Pfizer Introduction and Business Overview
Table 180. Pfizer Huntington's Disease Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 181. Pfizer Huntington's Disease Treatment Product
Table 182. Pfizer Recent Development
Table 183. Palobiofarma Company Information
Table 184. Palobiofarma Introduction and Business Overview
Table 185. Palobiofarma Huntington's Disease Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 186. Palobiofarma Huntington's Disease Treatment Product
Table 187. Palobiofarma Recent Development
Table 188. Omeros Company Information
Table 189. Omeros Introduction and Business Overview
Table 190. Omeros Huntington's Disease Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 191. Omeros Huntington's Disease Treatment Product
Table 192. Omeros Recent Development
Table 193. Ipsen Company Information
Table 194. Ipsen Introduction and Business Overview
Table 195. Ipsen Huntington's Disease Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 196. Ipsen Huntington's Disease Treatment Product
Table 197. Ipsen Recent Development
Table 198. Valeant Pharmaceuticals International Inc Company Information
Table 199. Valeant Pharmaceuticals International Inc Introduction and Business Overview
Table 200. Valeant Pharmaceuticals International Inc Huntington's Disease Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 201. Valeant Pharmaceuticals International Inc Huntington's Disease Treatment Product
Table 202. Valeant Pharmaceuticals International Inc Recent Development
Table 203. Key Raw Materials Lists
Table 204. Raw Materials Key Suppliers Lists
Table 205. Huntington's Disease Treatment Market Trends
Table 206. Huntington's Disease Treatment Market Drivers
Table 207. Huntington's Disease Treatment Market Challenges
Table 208. Huntington's Disease Treatment Market Restraints
Table 209. Huntington's Disease Treatment Distributors List
Table 210. Huntington's Disease Treatment Downstream Customers
Table 211. Research Programs/Design for This Report
Table 212. Key Data Information from Secondary Sources
Table 213. Key Data Information from Primary Sources
List of Figures
Figure 1. Huntington's Disease Treatment Product Picture
Figure 2. Global Huntington's Disease Treatment Market Size, 2018 VS 2024 VS 2034 (US$ Million)
Figure 3. Global Huntington's Disease Treatment Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Huntington's Disease Treatment Sales Status and Outlook (2018-2034) & (K Units)
Figure 5. Product Picture of Tetrabenazine
Figure 6. Global Tetrabenazine Sales YoY Growth (2018-2034) & (K Units)
Figure 7. Product Picture of Selective Serotonin Reuptake Inhibitor
Figure 8. Global Selective Serotonin Reuptake Inhibitor Sales YoY Growth (2018-2034) & (K Units)
Figure 9. Product Picture of Chlorpromazine
Figure 10. Global Chlorpromazine Sales YoY Growth (2018-2034) & (K Units)
Figure 11. Product Picture of Haloperidol
Figure 12. Global Haloperidol Sales YoY Growth (2018-2034) & (K Units)
Figure 13. Product Picture of Risperidone
Figure 14. Global Risperidone Sales YoY Growth (2018-2034) & (K Units)
Figure 15. Product Picture of Olanzapine
Figure 16. Global Olanzapine Sales YoY Growth (2018-2034) & (K Units)
Figure 17. Product Picture of Clozapine
Figure 18. Global Clozapine Sales YoY Growth (2018-2034) & (K Units)
Figure 19. Product Picture of Other
Figure 20. Global Other Sales YoY Growth (2018-2034) & (K Units)
Figure 21. Global Huntington's Disease Treatment Sales by Type (2018-2034) & (US$ Million)
Figure 22. Global Huntington's Disease Treatment Sales Market Share by Type in 2024 & 2034
Figure 23. North America Huntington's Disease Treatment Sales Market Share in Volume by Type in 2024
Figure 24. North America Huntington's Disease Treatment Sales Market Share in Value by Type in 2024
Figure 25. Europe Huntington's Disease Treatment Sales Market Share in Volume by Type in 2024
Figure 26. Europe Huntington's Disease Treatment Sales Market Share in Value by Type in 2024
Figure 27. Asia-Pacific Huntington's Disease Treatment Sales Market Share in Volume by Type in 2024
Figure 28. Asia-Pacific Huntington's Disease Treatment Sales Market Share in Value by Type in 2024
Figure 29. Latin America Huntington's Disease Treatment Sales Market Share in Volume by Type in 2024
Figure 30. Latin America Huntington's Disease Treatment Sales Market Share in Value by Type in 2024
Figure 31. Middle East and Africa Huntington's Disease Treatment Sales Market Share in Volume by Type in 2024
Figure 32. Middle East and Africa Huntington's Disease Treatment Sales Market Share in Value by Type in 2024
Figure 33. The 5 and 10 Largest Manufacturers in the World: Market Share by Huntington's Disease Treatment Sales in 2024
Figure 34. The 5 and 10 Largest Manufacturers in the World: Market Share by Huntington's Disease Treatment Revenue in 2024
Figure 35. Huntington's Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2024
Figure 36. Product Picture of Hospital
Figure 37. Global Hospital Sales YoY Growth (2018-2034) & (K Units)
Figure 38. Product Picture of Specialty Clinic
Figure 39. Global Specialty Clinic Sales YoY Growth (2018-2034) & (K Units)
Figure 40. Product Picture of other
Figure 41. Global other Sales YoY Growth (2018-2034) & (K Units)
Figure 42. Global Huntington's Disease Treatment Sales by Application (2018-2034) & (US$ Million)
Figure 43. Global Huntington's Disease Treatment Sales Market Share by Application in 2024 & 2034
Figure 44. North America Huntington's Disease Treatment Sales Market Share in Volume by Application in 2024
Figure 45. North America Huntington's Disease Treatment Sales Market Share in Value by Application in 2024
Figure 46. Europe Huntington's Disease Treatment Sales Market Share in Volume by Application in 2024
Figure 47. Europe Huntington's Disease Treatment Sales Market Share in Value by Application in 2024
Figure 48. Asia-Pacific Huntington's Disease Treatment Sales Market Share in Volume by Application in 2024
Figure 49. Asia-Pacific Huntington's Disease Treatment Sales Market Share in Value by Application in 2024
Figure 50. Latin America Huntington's Disease Treatment Sales Market Share in Volume by Application in 2024
Figure 51. Latin America Huntington's Disease Treatment Sales Market Share in Value by Application in 2024
Figure 52. Middle East and Africa Huntington's Disease Treatment Sales Market Share in Value by Application in 2024
Figure 53. Key Raw Materials Price
Figure 54. Huntington's Disease Treatment Manufacturing Cost Structure
Figure 55. Huntington's Disease Treatment Industrial Chain Analysis
Figure 56. Channels of Distribution
Figure 57. Distributors Profiles
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries